Compare ARK Genomic Revolution ETF (ARKG) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs YieldMax Universe Fund of Option Income ETFs — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while YieldMax Universe Fund of Option Income ETFs trades at $7.86. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| ARKG | YMAX | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $14.00 |
52-Week Low | $23.09 | $7.51 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
YMAX trades at $7.92, down 0.75% today, with technical indicators showing a neutral to bearish bias. The ETF maintains a consistent weekly dividend distribution strategy, though key valuation and profitability metrics remain unavailable. Recent news highlights the fund's focus on generating income through covered call strategies on a portfolio of YieldMax ETFs.
The outlook centers on YMAX's high distribution yield strategy, which faces headwinds from the bearish moving average signal and market volatility dependence. Investment appeal lies in income generation, but risks include the fund's complex options strategy and expense ratio of 1.33%, with most distributions representing return of capital rather than earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
